Details for 2013792149
Up to date per 01.04.2026
Actions
Details for 2013792149
Granted/Registered
European Patent
09.09.2015 A
05.09.2018 B1
02.11.2012
US
201261721622 P
20.11.2012
US
201261728328 P
28.02.2013
US
201361770668 P
16.05.2013
US
201361824005 P
28.06.2013
US
201361840668 P
A61K 9/20 20060101AFI20140522BHEP
Owner
Vertex Pharmaceuticals Incorporated50 Northern Avenue Boston, MA 02210US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
VERWIJS, Marinus, Jacobus4 Carter Drive Framingham, MA 01701US
KARKARE, Radhika31 Harvard Avenue 44 Medford, MA 02155US
MOORE, Michael, Douglas22 Prospect Street Unit 1 Charlestown, MA 02129US
Information about Fees